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ABSTRACT:
Objective: To identify a consistent pattern of brain MRI imaging in primary complex I deficiency. Complex I deficiency, major cause of respiratory chain dysfunction, accounts for various clinical presentations, including Leigh syndrome. Human complex I comprises seven core subunits encoded by mitochondrial DNA (mtDNA) and 38 core subunits encoded by nuclear DNA (nDNA). Moreover, its assembly requires six known and many unknown assembly factors. To date, no correlation between genotypes and brain MRI phenotypes has been found in complex I deficiencies.
Design and Subjects: We have retrospectively collected the brain MRIs of 30 patients carrying known mutation(s) in genes involved in complex I and compared them with the brain MRIs of 11 patients carrying known mutations in genes involved in the pyruvate dehydrogenase (PDH) complex as well as 10 patients with MT-TL1 mutations.
Results: All complex I deficient patients showed bilateral brainstem lesions (30/30) and 77% (23/30) showed anomalies of the putamen. Supra-tentorial stroke-like lesions were only observed in complex I-deficient patients carrying mtDNA mutations (8/19) and necrotizing leukoencephalopathy in patients with nDNA mutations (4/5). Conversely, the isolated strokelike images observed in patients with MT-TL1 mutations, or the corpus callosum malformations observed in PDH-deficient patients, were never observed in complex Ideficient patients.
Conclusion: We identified a common pattern of brain MRI imaging with abnormal signal intensities in brainstem and subtentorial nuclei with lactate-peak as a clue of complex I deficiency. We suggest that combining clinico-biochemical data with brain imaging can help orient genetic studies in complex I deficiency. While MRI abnormalities have been reported in patients with respiratory chain disorders, including those presenting complex I deficiency, no correlation between genotypes and brain MRI phenotypes has been hitherto reported in a large series of patients.
INTRODUCTION
We have retrospectively collected brain MRI and/or CT-scan of 30 complex I deficient patients carrying known mutations and compared them with the brain MRI of 11 patients with known mutations in pyruvate dehydrogenase (PDH) genes and 10 patients with MT-TL1 mutations. This retrospective study allows us to identify a consistent pattern of brain MRI imaging in primary complex I deficiency.
PATIENTS AND METHODS

Patients
Brain MRI in complex I deficiency-5 A total of 30 patients with complex I deficiency (25 males, 5 females) were included in this study. Inclusion criteria were i) known mutation(s) in either mtDNA or nuclear genes, ii) availability of brain imaging for review. The mean age at imaging ranged from to 2 months to 30 years (mean = 6.8 years). Their brain MRIs were compared to those of 11 patients (8 males, 3 females) with known PDH mutation(s) and 10 patients (5 males, 5 females) with MRIs were acquired with a 1 or 1.5-Tesla Signa GE. For the majority of patients, scans were all collected on the same MRI scanner with the same protocol. For a few patients, brain MRIs had been performed many years ago or in other hospitals. Missing images or data were reported as non available (na). CT-scan was the only available brain images for two complex Interestingly, stroke-like lesions predominantly affecting gray matter and not confined to arterial vascular territories were observed in 40% of patients carrying mtDNA mutations (8/20) but in none of the patients carrying nDNA mutations (p <0.05) (Fig 2A-C) .
A diffuse supratentorial leukoencephalopathy involving the deep lobar white matter was observed in 50% of patients with nDNA mutations (5/10) but in none of the patients carrying mtDNA mutations. The leukoencephalopathy was most likely necrotizing in 4/5 patients, including 3/4 patients with NDUFS1 mutations. FLAIR sequences were available for 2/4 patients with abnormal white matter containing cysts ( Fig 2D) . In the 2/4 others patients, lesions were markedly hyperintense on T2 and very hypointense on T1 weighted images, suggesting cysts (Fig 2E-F) .
Cerebellar hyperintensities were present in 13/29 patients (45%) regardless the mutated genome. Cerebellar atrophy was observed in 9/12 patients carrying mtDNA mutation aged 5 years (75%) but neither below five years nor in patients carrying nDNA mutations.
Spinal cord was not usually explored but T2 hyperintensities were observed in all three cases studied. When magnetic resonance spectroscopy (MRS) was performed and voxels placed over the brain lesions, important lactate peaks were consistently found in all patients (10/10), independent of the type of mutation (mtDNA or nDNA).
Patients with nDNA mutations presented significantly earlier brain anomalies than patients with mtDNA mutations (2.8 years and 8.9 respectively, p <0.05).
A group of 11 PDH-deficient patients and 10 patients with MT-TL1 mutations was chosen as control group (Tables 3-4 14 . The almost consistent detection of a lactate peak in our series supports the view that MRS should be performed in all patients with suspected complex I deficiency.
Abnormal brain images were observed significantly earlier in patients with nDNA mutations than in patients with mtDNA mutations. The age at onset was not determined by the date of the brain imaging; however, this could suggest an earlier clinical presentation for patients with nDNA mutations. For mtDNA mutations, heteroplasmic load has been shown to correlate with age at onset 15 . In this retrospective study, samples were not available anymore to quantify it. However, heteroplasmic load may contribute to explain later diagnosis for patients with mtDNA mutation (compared to patients with nDNA mutations) and the differences in brain image findings in patients with a same mtDNA mutation.
Supra-tentorial stroke-like lesions, similar to that observed in MT-TL1 16 , CABC1 17 or POLG 18 mutations, were only observed in patients with mtDNA mutations. CT-scans showed no evidence of calcifications in these patients with stroke-like lesions. As brainstem lesions are usually not observed in patients with mutations in MT-TL1 16 (Table 3) , CABC1 17 or POLG 18 , the combination of brainstem anomalies with stroke-like images, but without calcifications, should help focusing on the mtDNA-encoded complex I genes. In contrast, stroke-like images with calcifications and without brainstem anomalies should prompt to screen for MT-TL1 mutations 19 .
In this study, necrotizing leukoencephalopathy was found in patients carrying nuclear genes mutations as already described in NDUFA12L 20 and Aicardi-Goutières syndrome (AGS) 22 .
Apart from complex I deficiency, brain MRI involvement of brainstem and basal ganglia anomalies have also been reported in cases of Leigh syndromes ascribed to SURF1
and MT-ATP6 mutations [23] [24] [25] [26] [27] [28] . Similarly, brain MRI imaging of patients carrying RanBP2 mutations is relatively similar to that observed in LS patients and reportedly includes brainstem and thalamus lesions 29 . Yet, reported RanBP2 patients never presented the striatal anomalies that are constantly observed in our complex I deficient patients. Therefore the presence of striatal anomalies may help to distinguish between the two diagnoses.
Magnetic resonance spectroscopy (MRS) data were obtained only in 10/30 patients and an important lactate peak was consistently found in all patients. MRS is usually regarded as a more sensitive tool than CSF lactate 30 . For this reason, MRS should explore brainstem or white matter (in case of leukoencephalopathy) in complex I deficiency.
In conclusion, this retrospective study supports the view that mutations in complex I genes cause a common pattern of brain MRI imaging. We suggest giving consideration to association of brainstem and basal ganglia anomalies with lactate peak but no corpus callosum dysmorphism as a clue of complex I deficiency. When associated with stroke-like lesions or cerebellar atrophy, these images should prompt to screen for mtDNA mutations.
Finally, a necrotizing leukoencephalopathy should prompt to look for nuclear genes mutations.
Hence, brain imaging may help focusing on specific genes and contribute to faster gene identification in respiratory chain deficiency. 
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